U.S. markets closed
  • S&P 500

    3,269.96
    -40.15 (-1.21%)
     
  • Dow 30

    26,501.60
    -157.51 (-0.59%)
     
  • Nasdaq

    10,911.59
    -274.00 (-2.45%)
     
  • Russell 2000

    1,538.48
    -23.10 (-1.48%)
     
  • Crude Oil

    35.72
    -0.45 (-1.24%)
     
  • Gold

    1,878.80
    +10.80 (+0.58%)
     
  • Silver

    23.72
    +0.35 (+1.52%)
     
  • EUR/USD

    1.1641
    -0.0037 (-0.31%)
     
  • 10-Yr Bond

    0.8600
    +0.0250 (+2.99%)
     
  • GBP/USD

    1.2953
    +0.0030 (+0.23%)
     
  • USD/JPY

    104.6350
    +0.0250 (+0.02%)
     
  • BTC-USD

    13,824.69
    +105.89 (+0.77%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • FTSE 100

    5,577.27
    -4.48 (-0.08%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

Global Polymerase Chain Reaction Industry

ReportLinker
·25 mins read

Global Polymerase Chain Reaction Market to Reach $11 Billion by 2027. Amid the COVID-19 crisis, the global market for Polymerase Chain Reaction estimated at US$7. 8 Billion in the year 2020, is projected to reach a revised size of US$11 Billion by 2027, growing at aCAGR of 5% over the period 2020-2027.

New York, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Polymerase Chain Reaction Industry" - https://www.reportlinker.com/p05957722/?utm_source=GNW
Instruments, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Consumables segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 7.7% CAGR

The Polymerase Chain Reaction market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2027 trailing a CAGR of 7.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.We bring years of research experience to this 9th edition of our report. The 279-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Molecular, Inc.

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • bioMerieux SA

  • Bio-Rad Laboratories, Inc.

  • Danaher Corporation

  • F. Hoffmann-La Roche AG

  • QIAGEN NV

  • Siemens Healthcare GmbH

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p05957722/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Polymerase Chain Reaction Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Polymerase Chain
Reaction by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 2: World Historic Review for Polymerase Chain Reaction by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 3: World 15-Year Perspective for Polymerase Chain
Reaction by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reagents &
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 8: World Historic Review for Reagents & Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 9: World 15-Year Perspective for Reagents & Consumables
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Academic &
Research Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 11: World Historic Review for Academic & Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 12: World 15-Year Perspective for Academic & Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 13: World Current & Future Analysis for Clinical
Diagnostic Labs & Hospitals by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027

Table 14: World Historic Review for Clinical Diagnostic Labs &
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 15: World 15-Year Perspective for Clinical Diagnostic
Labs & Hospitals by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 16: World Current & Future Analysis for Pharmaceutical &
Biotechnology Sector by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 17: World Historic Review for Pharmaceutical &
Biotechnology Sector by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 18: World 15-Year Perspective for Pharmaceutical &
Biotechnology Sector by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Polymerase Chain Reaction Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 22: USA Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 23: USA Historic Review for Polymerase Chain Reaction by
Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 24: USA 15-Year Perspective for Polymerase Chain Reaction
by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 25: USA Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 26: USA Historic Review for Polymerase Chain Reaction by
End-Use - Academic & Research Institutes, Clinical Diagnostic
Labs & Hospitals, Pharmaceutical & Biotechnology Sector and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 27: USA 15-Year Perspective for Polymerase Chain Reaction
by End-Use - Percentage Breakdown of Value Sales for Academic &
Research Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses for
the Years 2012, 2020 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 29: Canada Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 30: Canada 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 31: Canada Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 32: Canada Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 33: Canada 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 35: Japan Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 36: Japan 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 37: Japan Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 38: Japan Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 39: Japan 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 41: China Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 42: China 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 43: China Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 44: China Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 45: China 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Polymerase Chain Reaction Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 46: Europe Current & Future Analysis for Polymerase Chain
Reaction by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 47: Europe Historic Review for Polymerase Chain Reaction
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 48: Europe 15-Year Perspective for Polymerase Chain
Reaction by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 50: Europe Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 51: Europe 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 52: Europe Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 53: Europe Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 54: Europe 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 56: France Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 57: France 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 58: France Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 59: France Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 60: France 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Polymerase
Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 62: Germany Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 63: Germany 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 64: Germany Current & Future Analysis for Polymerase
Chain Reaction by End-Use - Academic & Research Institutes,
Clinical Diagnostic Labs & Hospitals, Pharmaceutical &
Biotechnology Sector and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 65: Germany Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 66: Germany 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 68: Italy Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 69: Italy 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 70: Italy Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 71: Italy Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 72: Italy 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 74: UK Historic Review for Polymerase Chain Reaction by
Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 75: UK 15-Year Perspective for Polymerase Chain Reaction
by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 76: UK Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 77: UK Historic Review for Polymerase Chain Reaction by
End-Use - Academic & Research Institutes, Clinical Diagnostic
Labs & Hospitals, Pharmaceutical & Biotechnology Sector and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 78: UK 15-Year Perspective for Polymerase Chain Reaction
by End-Use - Percentage Breakdown of Value Sales for Academic &
Research Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses for
the Years 2012, 2020 & 2027

SPAIN
Table 79: Spain Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 80: Spain Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 81: Spain 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 82: Spain Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 83: Spain Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 84: Spain 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

RUSSIA
Table 85: Russia Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 86: Russia Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 87: Russia 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 88: Russia Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 89: Russia Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 90: Russia 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for
Polymerase Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 92: Rest of Europe Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 93: Rest of Europe 15-Year Perspective for Polymerase
Chain Reaction by Segment - Percentage Breakdown of Value Sales
for Instruments and Reagents & Consumables for the Years 2012,
2020 & 2027

Table 94: Rest of Europe Current & Future Analysis for
Polymerase Chain Reaction by End-Use - Academic & Research
Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 95: Rest of Europe Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 96: Rest of Europe 15-Year Perspective for Polymerase
Chain Reaction by End-Use - Percentage Breakdown of Value Sales
for Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Polymerase
Chain Reaction by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 98: Asia-Pacific Historic Review for Polymerase Chain
Reaction by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 99: Asia-Pacific 15-Year Perspective for Polymerase Chain
Reaction by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 100: Asia-Pacific Current & Future Analysis for
Polymerase Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 101: Asia-Pacific Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 102: Asia-Pacific 15-Year Perspective for Polymerase
Chain Reaction by Segment - Percentage Breakdown of Value Sales
for Instruments and Reagents & Consumables for the Years 2012,
2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for
Polymerase Chain Reaction by End-Use - Academic & Research
Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 104: Asia-Pacific Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 105: Asia-Pacific 15-Year Perspective for Polymerase
Chain Reaction by End-Use - Percentage Breakdown of Value Sales
for Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

AUSTRALIA
Table 106: Australia Current & Future Analysis for Polymerase
Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 107: Australia Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 108: Australia 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 109: Australia Current & Future Analysis for Polymerase
Chain Reaction by End-Use - Academic & Research Institutes,
Clinical Diagnostic Labs & Hospitals, Pharmaceutical &
Biotechnology Sector and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 110: Australia Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 111: Australia 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

INDIA
Table 112: India Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 113: India Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 114: India 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 115: India Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 116: India Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 117: India 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 118: South Korea Current & Future Analysis for Polymerase
Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 119: South Korea Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 120: South Korea 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027

Table 121: South Korea Current & Future Analysis for Polymerase
Chain Reaction by End-Use - Academic & Research Institutes,
Clinical Diagnostic Labs & Hospitals, Pharmaceutical &
Biotechnology Sector and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 122: South Korea Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 123: South Korea 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957722/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001